NCT00240695: A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment |
|
|
| Completed | 3 | 724 | US | galantamine hydrobromide | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Cognition Disorder, Nervous System Diseases, Mental Disorders, Brain Diseases | | 05/04 | | |
NCT00216502: A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease |
|
|
| Completed | 3 | 254 | Europe | galantamine hydrobromide | Janssen-Cilag S.p.A. | Alzheimer Disease, Dementia, Mental Disorders, Brain Diseases | | 11/05 | | |
| Completed | 3 | 39 | US | Razadyne, Galantamine, Placebo | Massachusetts General Hospital, Ortho-McNeil Janssen Scientific Affairs, LLC | Major Depression, Bipolar Depression, Schizoaffective Disorder | 01/08 | 01/08 | | |
